素青素G 缺乏和二次梅毒
William Snider1, Ian Depew1, Shane Cook1
1Dermatology, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Cureus
|September 13, 2024
概括
素青素G (BPG) 的短缺,主要的梅毒治疗,影响患者的护理. 本案例报告强调了BPG不可用期间梅毒的挑战和替代管理策略.
科学领域:
- 传染性疾病 传染性疾病
- 细菌学 细菌学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 梅毒是一种由*Treponema pallidum*引起的性传播感染,呈现四个阶段.
- 早期梅毒 (初级,二级) 和晚期梅毒 (三级) 有不同的表现.
- 晚期梅毒会导致不可逆转的神经和心血管损伤,增加死亡风险.
研究的目的:
- 报告一例二次梅毒病例,该病例在奔氨酸青素G (BPG) 短缺期间得到治疗.
- 讨论BPG不可用性对梅毒治疗的影响.
- 在资源有限的环境中探索替代管理策略.
主要方法:
- 一个患有二次性梅毒的患者的病例报告,表现为皮肤病变.
- 由于BPG不可用,初步用多西环林治疗.
- 在为期八天的搜索后,BPG的管理.
主要成果:
- 患者最初接受了多西环林,随后是BPG.
- 该案强调了在获得基本抗菌药物治疗方面面临的重大挑战.
- BPG短缺影响梅毒管理和潜在的其他抗菌疗法.
结论:
- BPG的稀缺性对有效的梅毒治疗构成严重威胁.
- 在药物短缺期间,替代治疗方法和策略对于治疗梅毒至关重要.
- 解决抗微生物药物供应链问题对于公共卫生至关重要,特别是在资源有限的地区.
相关概念视频
Sexually Transmitted Infections
286
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
286
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Pulmonary Tuberculosis V
172
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
172
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II
214
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
214
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K


